Tamusulosin
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Urinary Tract Diseases
Conditions
Urinary Tract Diseases
Trial Timeline
— → —
NCT ID
NCT00239317About Tamusulosin
Tamusulosin is a phase 3 stage product being developed by Astellas Pharma for Urinary Tract Diseases. The current trial status is completed. This product is registered under clinical trial identifier NCT00239317. Target conditions include Urinary Tract Diseases.
What happened to similar drugs?
20 of 20 similar drugs in Urinary Tract Diseases were approved
Approved (20) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00239317 | Phase 3 | Completed |
Competing Products
20 competing products in Urinary Tract Diseases